Maria Pigini

1.6k total citations
85 papers, 1.3k citations indexed

About

Maria Pigini is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Maria Pigini has authored 85 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 38 papers in Cellular and Molecular Neuroscience and 30 papers in Organic Chemistry. Recurrent topics in Maria Pigini's work include Receptor Mechanisms and Signaling (43 papers), Neurotransmitter Receptor Influence on Behavior (23 papers) and Pharmacological Receptor Mechanisms and Effects (17 papers). Maria Pigini is often cited by papers focused on Receptor Mechanisms and Signaling (43 papers), Neurotransmitter Receptor Influence on Behavior (23 papers) and Pharmacological Receptor Mechanisms and Effects (17 papers). Maria Pigini collaborates with scholars based in Italy, France and United States. Maria Pigini's co-authors include Wilma Quaglia, Alessandro Piergentili, Mario Giannella, Carlo Melchiorre, Livio Brasili, Francesco Gentili, Fulvio Gualtieri, Antonio Carrieri, Fabio Del Bello and Amedeo Leonardi and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Maria Pigini

81 papers receiving 1.3k citations

Peers

Maria Pigini
Elena Poggesi Italy
Livio Brasili Italy
Mario Giannella Italy
Wilma Quaglia Italy
Charles Gluchowski United States
Angus M. MacLeod United Kingdom
Giorgio Cignarella Italy
Dianne Kowal United States
Lawrence D. Wise United States
Durk Dijkstra Netherlands
Elena Poggesi Italy
Maria Pigini
Citations per year, relative to Maria Pigini Maria Pigini (= 1×) peers Elena Poggesi

Countries citing papers authored by Maria Pigini

Since Specialization
Citations

This map shows the geographic impact of Maria Pigini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Pigini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Pigini more than expected).

Fields of papers citing papers by Maria Pigini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Pigini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Pigini. The network helps show where Maria Pigini may publish in the future.

Co-authorship network of co-authors of Maria Pigini

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Pigini. A scholar is included among the top collaborators of Maria Pigini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Pigini. Maria Pigini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mannelli, Lorenzo Di Cesare, Carla Ghelardini, Laura Micheli, et al.. (2017). Synergic stimulation of serotonin 5-HT1A receptor and α2-adrenoceptors for neuropathic pain relief: Preclinical effects of 2-substituted imidazoline derivatives. European Journal of Pharmacology. 810. 128–133. 18 indexed citations
2.
Caprioli, Giovanni, Massimo Ricciutelli, Gianni Sagratini, et al.. (2015). Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation. European Journal of Pharmacology. 769. 219–224. 2 indexed citations
3.
Ubaldi, Massimo, Fabio Del Bello, Esi Domi, Maria Pigini, & Cinzia Nasuti. (2015). Investigation of allyphenyline efficacy in the treatment of alcohol withdrawal symptoms. European Journal of Pharmacology. 760. 122–128. 5 indexed citations
4.
Quaglia, Wilma, Fabio Del Bello, Mario Giannella, Alessandro Piergentili, & Maria Pigini. (2011). α2C-adrenoceptor modulators: a patent review. Expert Opinion on Therapeutic Patents. 21(4). 455–481. 10 indexed citations
5.
Giorgioni, Gianfabio, Alan L. Hudson, Cinzia Nasuti, et al.. (2010). Novel imidazoline compounds as partial or full agonists of D2-like dopamine receptors inspired by I2-imidazoline binding sites ligand 2-BFI. Bioorganic & Medicinal Chemistry. 18(19). 7085–7091. 13 indexed citations
6.
Carrieri, Antonio, Alessandro Piergentili, Fabio Del Bello, et al.. (2010). Structure–activity relationships in 1,4-benzodioxan-related compounds. 10. Novel α1-adrenoreceptor antagonists related to openphendioxan: Synthesis, biological evaluation, and α1d computational study. Bioorganic & Medicinal Chemistry. 18(19). 7065–7077. 12 indexed citations
7.
Piergentili, Alessandro, Wilma Quaglia, Fabio Del Bello, et al.. (2009). Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation. Bioorganic & Medicinal Chemistry. 17(24). 8174–8185. 13 indexed citations
8.
Piergentili, Alessandro, Piero Angeli, Roberto Gagliardi, et al.. (2002). Design, synthesis and muscarinic activity of deoxamuscarine-related derivatives. Medicinal Chemistry Research. 11(1). 12–23. 1 indexed citations
9.
Angeli, Piero, Gabriella Marucci, Michela Buccioni, et al.. (2002). Deoxamuscaroneoxime derivatives as useful muscarinic agonists to explore the muscarinic subsite. Life Sciences. 70(12). 1427–1446. 1 indexed citations
10.
Polidori, Carlo, et al.. (2000). Hyperphagic effect of novel compounds with high affinity for imidazoline I2 binding sites. European Journal of Pharmacology. 392(1-2). 41–49. 25 indexed citations
11.
Melchiorre, Carlo, María Laura Bolognesi, Alberto Chiarini, et al.. (2000). α1-Adrenoreceptor antagonists bearing a quinazoline or a benzodioxane moiety. Pharmaceutica Acta Helvetiae. 74(2-3). 181–190. 14 indexed citations
12.
Ferretti, Giovanni, Maƚgorzata Dukat, Maddalena Giannella, et al.. (2000). Chain-lengthened and imidazoline analogues of nicotine. Bioorganic & Medicinal Chemistry Letters. 10(23). 2665–2668. 9 indexed citations
13.
Pigini, Maria, Wilma Quaglia, Francesco Gentili, et al.. (2000). Structure–activity relationship at α-adrenergic receptors within a series of imidazoline analogues of cirazoline. Bioorganic & Medicinal Chemistry. 8(5). 883–888. 10 indexed citations
14.
Pigini, Maria, Pascal Bousquet, Livio Brasili, et al.. (1998). Ligand binding to I2 imidazoline receptor: The role of lipophilicity in quantitative structure—activity relationship models. Bioorganic & Medicinal Chemistry. 6(12). 2245–2260. 26 indexed citations
15.
Tayebati, Seyed Khosrow, Alessandro Piergentili, Maria Pigini, et al.. (1997). Use of Frozen Sections for the Pharmacological Characterization of Compounds Active on Neurotransmitter Receptors. Clinical and Experimental Hypertension. 19(7). 1023–1046. 3 indexed citations
16.
Tayebati, Seyed Khosrow, Mario Giannella, Maria Pigini, et al.. (1997). Muscarinic Cholinergic Receptors and Acetylcholinesterase Activity in Umbilical Artery and Vein in Pregnancy-Induced Hypertension (Pre-Eclampsia). Clinical and Experimental Hypertension. 19(8). 1205–1217. 6 indexed citations
17.
Piergentili, Alessandro, Maria Pigini, Wilma Quaglia, et al.. (1996). Muscarinic thioligands with cyclopentane nucleus. Bioorganic & Medicinal Chemistry. 4(12). 2193–2199. 2 indexed citations
18.
Brasili, Livio, Maria Pigini, Annick Molines, et al.. (1995). Structure‐Affinity Relationship of Cirazoline Derivatives for Idazoxan Imidazoline‐Specific Sites in the Human Cerebral Cortex and the Rabbit Kidney. Annals of the New York Academy of Sciences. 763(1). 149–152. 1 indexed citations
19.
Giannella, Mario, et al.. (1994). Synthesis and Muscarinic Properties of (1S*,3R*,5R*)-Trimethyl(1-methyl-6-oxabicyclo(3.1.0)hex-3-yl)methyl Ammonium Iodide.. Chemical and Pharmaceutical Bulletin. 42(6). 1286–1290.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Poggesi Breakdown of academic impact, for papers by Livio Brasili Breakdown of academic impact, for papers by Mario Giannella Breakdown of academic impact, for papers by Wilma Quaglia Breakdown of academic impact, for papers by Charles Gluchowski Breakdown of academic impact, for papers by Angus M. MacLeod Breakdown of academic impact, for papers by Giorgio Cignarella Breakdown of academic impact, for papers by Dianne Kowal Breakdown of academic impact, for papers by Lawrence D. Wise Breakdown of academic impact, for papers by Durk Dijkstra
Rankless by CCL
2026